表紙
市場調查報告書

組織診斷的全球市場:各產品、技術、用途、終端用戶,及各地區的預測 (2020-2027年)

Global Tissue Diagnostics Market Size study, by Product, Technology, by Application, by End-User and Regional Forecasts 2020-2027

出版商 Bizwit Research & Consulting LLP 商品編碼 939896
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
組織診斷的全球市場:各產品、技術、用途、終端用戶,及各地區的預測 (2020-2027年) Global Tissue Diagnostics Market Size study, by Product, Technology, by Application, by End-User and Regional Forecasts 2020-2027
出版日期: 2020年05月01日內容資訊: 英文
簡介

全球組織診斷市場規模在2019年估算為約32億美金,預計2020年∼2027年的預測期間內將以6.5%以上的成長率擴大。組織診斷,主要以針吸引細胞診斷,核心切片檢查,開放式切片檢查進行。組織診斷的這些技術和設備的進步,有助於對組織相關疾病的迅速且正確的決策與評估。再加上自動化組織診斷系統的高引進率,高齡化人口的增加造成癌症的發生率增加,及全球性醫療保健成本的上升等,成為在預測期間內高年複合成長率的要素。

本報告提供全球組織診斷市場相關調查,市場概要,各產品、技術、應用、終端用戶及地區的市場的分析與預測,競爭情形分析,並提供主要企業簡介等資訊。

第1章 摘要整理

第2章 全球組織診斷市場定義和範圍

第3章 全球組織診斷市場動態

  • 影響分析

第4章 產業分析

  • 波特的五力分析
  • PEST分析
  • 投資採用模式
  • 分析師的建議與結論

第5章 全球組織診斷市場:各產品

  • 市場概述
  • 潛在性分析
  • 市場估計、預測: 各產品
  • 子區隔分析
    • 消耗品
    • 設備

第6章 全球組織診斷市場:各技術

  • 市場概述
  • 潛在性分析
  • 市場估計、預測:各技術
  • 子區隔分析
    • 免疫組織染色 (IHC)
    • 原位 雜合反應 (ISH)
    • 數位病理學、工作流程管理
    • 特殊染色法

第7章 全球組織診斷市場:各應用領域

  • 市場概述
  • 潛在性分析
  • 市場估計、預測: 各應用領域
  • 子區隔分析
    • 乳癌
    • 胃癌
    • 前列腺癌
    • 淋巴瘤
    • 非小細胞肺癌(NSCLC)
    • 其他

第8章 全球組織診斷市場:各終端用戶

  • 市場概述
  • 潛在性分析
  • 市場估計、預測: 各終端用戶
  • 子區隔分析
    • 醫院
    • 研究所
    • 醫藥品企業
    • CRO
    • 其他

第9章 全球組織診斷市場:地區分析

  • 地區市場概述
  • 北美
    • 美國
    • 加拿大
  • 歐洲的概述
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 其他歐洲
  • 亞太地區的概述
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • 其他亞太地區
  • 南美的概述
    • 巴西
    • 墨西哥
  • 其他地區

第10章 競爭資訊

  • 主要市場策略
  • 企業簡介
    • F. Hoffmann-La Roche AG
    • Danaher Corporation
    • Thermo Fisher Scientific
    • Abbott Laboratories
    • Agilent Technologies
    • Merck KGaA
    • Sakura Finetek Japan Co.,Ltd.
    • Becton, Dickinson and Company
    • Bio-Genex Laboratories
    • Hologic, Inc.

第11章 調查流程

目錄

Global Tissue Diagnostics Market is valued approximately USD 3.2 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 6.5% over the forecast period 2020-2027. Tissue diagnostics is rapidly serving as the gold standards for diagnosis of cancer. Tissue diagnostics is a type of technique used in removal of tissue from the patient's body, which is then processed, tested and analyzed under the microscope to perceive the diseases, such as cancer. Tissue diagnostics is primarily performed by needle aspiration cytology, core biopsy and open biopsy. The advancements in these techniques and equipment of tissue diagnostics helps in quick and precise determination and evaluation of diseases associated to the tissues. Further, high adoption of automated tissue diagnostics system, increasing incidences of cancer owing to growing aging population, and rise in healthcare expenditure across the globe are the few factors responsible for high CAGR of the market during the forecast period. As per the International Agency for Research on Cancer (IARC), around 17.0 million new cancer cases and 9.5 million cancer deaths were totaled in 2018 worldwide. Also, it is predicted that it would grow to almost 27.5 million new cancer cases and 16.3 million cancer deaths by 2040. With the rise in prevalence of cancer, the adoption & utility for tissue diagnostics is likely to grow around the world. Moreover, the outbreak of COVID-19 around the world stressed a major concern on the governments of all COVID-19 hit nations. Since, there is an excruciating need to test and screen a large number of patients for possible Sars-Cov-2 infection. As a result, most of the nations are facing a major shortage in the supply for diagnostic kits to test this virus. Therefore, tissue diagnostics virology suppliers are under immense pressure to deliver reliable testing kits, and therefore, there is a surge in demand for tissue diagnostics systems worldwide. However, high degree of consolidation and budget constraints are the factors impeding the growth of market over the forecast period of 2020-2027.

The regional analysis of global Tissue Diagnostics market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to increasing number of patients with COVID-19 infections, along with the ongoing advancements in the field of gene & immunoassay-based products in the region. Whereas, Asia-Pacific is anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2027. Factors such as rising elderly population, rising cases of cancer and improving healthcare infrastructure would create lucrative growth prospects for the tissue diagnostics market across Asia-Pacific region.

Major market player included in this report are:

F. Hoffmann-La Roche AG

Danaher Corporation

Thermo Fisher Scientific

Abbott Laboratories

Agilent Technologies

Merck KGaA

Sakura Finetek Japan Co., Ltd.

Becton, Dickinson and Company

Bio-Genex Laboratories

Hologic, Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

Consumables

Instruments

By Technology:

Immunohistochemistry (IHC)

In Situ Hybridization (ISH)

Digital Pathology and Workflow Management

Special Staining

By Application:

Breast Cancer

Gastric Cancer

Prostate Cancer

Lymphoma

Non-Small Cell Lung Cancer (NSCLC)

Others

By End-User:

Hospitals

Research Laboratories

Pharmaceutical Companies

Contract Research Organizations

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2017, 2018

Base year - 2019

Forecast period - 2020 to 2027

Target Audience of the Global Tissue Diagnostics Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
    • 1.2.1. Tissue Diagnostics Market, by Region, 2018-2027 (USD Billion)
    • 1.2.2. Tissue Diagnostics Market, by Product, 2018-2027 (USD Billion)
    • 1.2.3. Tissue Diagnostics Market, by Technology, 2018-2027 (USD Billion)
    • 1.2.4. Tissue Diagnostics Market, by Application, 2018-2027 (USD Billion)
    • 1.2.5. Tissue Diagnostics Market, by End-User, 2018-2027 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Tissue Diagnostics Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Tissue Diagnostics Market Dynamics

  • 3.1. Tissue Diagnostics Market Impact Analysis (2018-2027)
    • 3.1.1. Market Drivers
    • 3.1.2. Market Challenges
    • 3.1.3. Market Opportunities

Chapter 4. Global Tissue Diagnostics Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2017-2027)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Tissue Diagnostics Market, by Product

  • 5.1. Market Snapshot
  • 5.2. Global Tissue Diagnostics Market by Product, Performance - Potential Analysis
  • 5.3. Global Tissue Diagnostics Market Estimates & Forecasts by Product 2017-2027 (USD Billion)
  • 5.4. Tissue Diagnostics Market, Sub Segment Analysis
    • 5.4.1. Consumables
    • 5.4.2. Instruments

Chapter 6. Global Tissue Diagnostics Market, by Technology

  • 6.1. Market Snapshot
  • 6.2. Global Tissue Diagnostics Market by Technology, Performance - Potential Analysis
  • 6.3. Global Tissue Diagnostics Market Estimates & Forecasts by Technology 2017-2027 (USD Billion)
  • 6.4. Tissue Diagnostics Market, Sub Segment Analysis
    • 6.4.1. Immunohistochemistry (IHC)
    • 6.4.2. In Situ Hybridization (ISH)
    • 6.4.3. Digital Pathology and Workflow Management
    • 6.4.4. Special Staining

Chapter 7. Global Tissue Diagnostics Market, by Application

  • 7.1. Market Snapshot
  • 7.2. Global Tissue Diagnostics Market by Application - Potential Analysis
  • 7.3. Global Tissue Diagnostics Market Estimates & Forecasts by Application 2017-2027 (USD Billion)
  • 7.4. Tissue Diagnostics Market, Sub Segment Analysis
    • 7.4.1. Breast Cancer
    • 7.4.2. Gastric Cancer
    • 7.4.3. Prostate Cancer
    • 7.4.4. Lymphoma
    • 7.4.5. Non-Small Cell Lung Cancer (NSCLC)
    • 7.4.6. Others

Chapter 8. Global Tissue Diagnostics Market, by End-User

  • 8.1. Market Snapshot
  • 8.2. Global Tissue Diagnostics Market by End-User - Potential Analysis
  • 8.3. Global Tissue Diagnostics Market Estimates & Forecasts by End-User 2017-2027 (USD Billion)
  • 8.4. Tissue Diagnostics Market, Sub Segment Analysis
    • 8.4.1. Hospitals
    • 8.4.2. Research Laboratories
    • 8.4.3. Pharmaceutical Companies
    • 8.4.4. Contract Research Organizations
    • 8.4.5. Others

Chapter 9. Global Tissue Diagnostics Market, Regional Analysis

  • 9.1. Tissue Diagnostics Market, Regional Market Snapshot
  • 9.2. North America Tissue Diagnostics Market
    • 9.2.1. U.S. Tissue Diagnostics Market
      • 9.2.1.1. Product breakdown estimates & forecasts, 2017-2027
      • 9.2.1.2. Technology breakdown estimates & forecasts, 2017-2027
      • 9.2.1.3. Application breakdown estimates & forecasts, 2017-2027
      • 9.2.1.4. End-User breakdown estimates & forecasts, 2017-2027
    • 9.2.2. Canada Tissue Diagnostics Market
  • 9.3. Europe Tissue Diagnostics Market Snapshot
    • 9.3.1. U.K. Tissue Diagnostics Market
    • 9.3.2. Germany Tissue Diagnostics Market
    • 9.3.3. France Tissue Diagnostics Market
    • 9.3.4. Spain Tissue Diagnostics Market
    • 9.3.5. Italy Tissue Diagnostics Market
    • 9.3.6. Rest of Europe Tissue Diagnostics Market
  • 9.4. Asia-Pacific Tissue Diagnostics Market Snapshot
    • 9.4.1. China Tissue Diagnostics Market
    • 9.4.2. India Tissue Diagnostics Market
    • 9.4.3. Japan Tissue Diagnostics Market
    • 9.4.4. Australia Tissue Diagnostics Market
    • 9.4.5. South Korea Tissue Diagnostics Market
    • 9.4.6. Rest of Asia Pacific Tissue Diagnostics Market
  • 9.5. Latin America Tissue Diagnostics Market Snapshot
    • 9.5.1. Brazil Tissue Diagnostics Market
    • 9.5.2. Mexico Tissue Diagnostics Market
  • 9.6. Rest of The World Tissue Diagnostics Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. F. Hoffmann-La Roche AG
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Product Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. Danaher Corporation
    • 10.2.3. Thermo Fisher Scientific
    • 10.2.4. Abbott Laboratories
    • 10.2.5. Agilent Technologies
    • 10.2.6. Merck KGaA
    • 10.2.7. Sakura Finetek Japan Co.,Ltd.
    • 10.2.8. Becton, Dickinson and Company
    • 10.2.9. Bio-Genex Laboratories
    • 10.2.10. Hologic, Inc.

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption

LIST OF TABLES

  • TABLE 1. GLOBAL TISSUE DIAGNOSTICS MARKET, REPORT SCOPE
  • TABLE 2. GLOBAL TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY REGION 2017-2027 (USD BILLION)
  • TABLE 3. GLOBAL TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY PRODUCT 2017-2027 (USD BILLION)
  • TABLE 4. GLOBAL TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY TECHNOLOGY 2017-2027 (USD BILLION)
  • TABLE 5. GLOBAL TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY APPLICATION 2017-2027 (USD BILLION)
  • TABLE 6. GLOBAL TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY END-USER 2017-2027 (USD BILLION)
  • TABLE 7. GLOBAL TISSUE DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 8. GLOBAL TISSUE DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 9. GLOBAL TISSUE DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 10. GLOBAL TISSUE DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 11. GLOBAL TISSUE DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 12. GLOBAL TISSUE DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 13. GLOBAL TISSUE DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 14. GLOBAL TISSUE DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 15. GLOBAL TISSUE DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 16. GLOBAL TISSUE DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 17. U.S. TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 18. U.S. TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 19. U.S. TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 20. CANADA TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 21. CANADA TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 22. CANADA TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 23. UK TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 24. UK TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 25. UK TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 26. GERMANY TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 27. GERMANY TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 28. GERMANY TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 29. ROE TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 30. ROE TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 31. ROE TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 32. CHINA TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 33. CHINA TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 34. CHINA TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 35. INDIA TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 36. INDIA TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 37. INDIA TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 38. JAPAN TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 39. JAPAN TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 40. JAPAN TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 41. ROAPAC TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 42. ROAPAC TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 43. ROAPAC TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 44. BRAZIL TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 45. BRAZIL TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 46. BRAZIL TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 47. MEXICO TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 48. MEXICO TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 49. MEXICO TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 50. ROLA TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 51. ROLA TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 52. ROLA TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 53. ROW TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 54. ROW TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 55. ROW TISSUE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 56. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL TISSUE DIAGNOSTICS MARKET
  • TABLE 57. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL TISSUE DIAGNOSTICS MARKET
  • TABLE 58. YEARS CONSIDERED FOR THE STUDY
  • TABLE 59. EXCHANGE RATES CONSIDERED

LIST OF FIGURES

  • FIG 1. GLOBAL TISSUE DIAGNOSTICS MARKET, RESEARCH METHODOLOGY
  • FIG 2. GLOBAL TISSUE DIAGNOSTICS MARKET, MARKET ESTIMATION TECHNIQUES
  • FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
  • FIG 4. GLOBAL TISSUE DIAGNOSTICS MARKET, KEY TRENDS 2019
  • FIG 5. GLOBAL TISSUE DIAGNOSTICS MARKET, GROWTH PROSPECTS 2020-2027
  • FIG 6. GLOBAL TISSUE DIAGNOSTICS MARKET, PORTERS 5 FORCE MODEL
  • FIG 7. GLOBAL TISSUE DIAGNOSTICS MARKET, PEST ANALYSIS
  • FIG 8. GLOBAL TISSUE DIAGNOSTICS MARKET, VALUE CHAIN ANALYSIS
  • FIG 9. GLOBAL TISSUE DIAGNOSTICS MARKET BY SEGMENT, 2017 & 2027 (USD BILLION)
  • FIG 10. GLOBAL TISSUE DIAGNOSTICS MARKET BY SEGMENT, 2017 & 2027 (USD BILLION)
  • FIG 11. GLOBAL TISSUE DIAGNOSTICS MARKET BY SEGMENT, 2017 & 2027 (USD BILLION)
  • FIG 12. GLOBAL TISSUE DIAGNOSTICS MARKET BY SEGMENT, 2017 & 2027 (USD BILLION)
  • FIG 13. GLOBAL TISSUE DIAGNOSTICS MARKET BY SEGMENT, 2017 & 2027 (USD BILLION)
  • FIG 14. GLOBAL TISSUE DIAGNOSTICS MARKET, REGIONAL SNAPSHOT 2017 & 2027
  • FIG 15. NORTH AMERICA TISSUE DIAGNOSTICS MARKET 2017 & 2027 (USD BILLION)
  • FIG 16. EUROPE TISSUE DIAGNOSTICS MARKET 2017 & 2027 (USD BILLION)
  • FIG 17. ASIA PACIFIC TISSUE DIAGNOSTICS MARKET 2017 & 2027 (USD BILLION)
  • FIG 18. LATIN AMERICA TISSUE DIAGNOSTICS MARKET 2017 & 2027 (USD BILLION)
  • FIG 19. GLOBAL TISSUE DIAGNOSTICS MARKET, COMPANY MARKET SHARE ANALYSIS (2019)